Detailansicht

Wissensnetz

Person

Evelyn Ullrich (1976-)

Name	Evelyn Ullrich
Zeit	1976- (Lebensdaten)
Ort	Deutschland
Beziehung	Universitäts-Kinderklinik (Frankfurt am Main) Medizin (Thema)
Weitere Angaben	Diss. Medizinische Fakultät
Datensatztyp	Person
GND-Nummer	128600993
Datensatz-ID	128600993
Beteiligt an alle anzeigen Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia Anti-idiotype antibodies for biomedical applications CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells Generation and evaluation of chimeric antigen receptor-modified natural killer cells for the treatment of acute myeloid leukemia Immune profiling and functional analysis of NK and T cells in ataxia telangiectasia Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients Untersuchung der Rolle von BRD7 und DOT1L im Prä-B-Zellrezeptor-Signalweg Correction: Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma Editorial: Novel and improved methods for the prevention and treatment of Graft-Versus-Host Disease (GVHD) Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia Roles of MARCH5 and SASH3 in oncogenic signalling in B-cell Non-Hodgkin lymphoma SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy? COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view Unleashing the power of NK cells in anticancer immunotherapy Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy Characterization and manipulation of the crosstalk between dendritic and natural killer cells within the tumor microenvironment Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany Specific targeting of lymphoma cells using semisynthetic anti-idiotype shark antibodies Unleashing the power of NK cells in anticancer immunotherapy ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma High cytotoxic efficiency of lentivirally and alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia Highly efficient generation of transgenically augmented CAR NK cells overexpressing CXCR4 Tracking of infused mesenchymal stem cells in injured pulmonary tissue in Atm-deficient mice The synergistic use of il-15 and il-21 for the generation of nk cells from cd3/cd19-depleted grafts improves their ex vivo expansion and cytotoxic potential against neuroblastoma: Perspective for optimized immunotherapy post haploidentical stem cell transplantation Shaping of natural killer cell antitumor activity by ex vivo cultivation The smac mimetic BV6 improves NK cell-mediated killing of rhabdomyosarcoma cells by simultaneously targeting tumor and effector cells Relation between acute GVHD and NK cell subset reconstitution following allogeneic stem cell transplantation Wenn Zellen zu Medikamenten werden : neue Zelltherapien verbessern die Heilungschancen bei Leukämien [[Elektronische Ressource]] Novel immune modulators used in hematology: impact on NK cells Lokalisation des antiviralen Mx1-Proteins und seiner assoziierten Proteinkinase in nukleären Einschlusskörpern Lokalisation des antiviralen Mx1-Proteins und seiner assoziierten Proteinkinase in nukleären Einschlusskörpern

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Evelyn Ullrich (1976-)

Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia

Anti-idiotype antibodies for biomedical applications

CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells

Generation and evaluation of chimeric antigen receptor-modified natural killer cells for the treatment of acute myeloid leukemia

Immune profiling and functional analysis of NK and T cells in ataxia telangiectasia

Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis

Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients

Untersuchung der Rolle von BRD7 und DOT1L im Prä-B-Zellrezeptor-Signalweg

Correction: Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia

Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia

Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy

The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma

Editorial: Novel and improved methods for the prevention and treatment of Graft-Versus-Host Disease (GVHD)

Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy

Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia

Roles of MARCH5 and SASH3 in oncogenic signalling in B-cell Non-Hodgkin lymphoma

SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination

T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?

COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view

Unleashing the power of NK cells in anticancer immunotherapy

Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy

Characterization and manipulation of the crosstalk between dendritic and natural killer cells within the tumor microenvironment

Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment

Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany

Specific targeting of lymphoma cells using semisynthetic anti-idiotype shark antibodies

Unleashing the power of NK cells in anticancer immunotherapy

ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma

High cytotoxic efficiency of lentivirally and alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia

Highly efficient generation of transgenically augmented CAR NK cells overexpressing CXCR4

Tracking of infused mesenchymal stem cells in injured pulmonary tissue in Atm-deficient mice

The synergistic use of il-15 and il-21 for the generation of nk cells from cd3/cd19-depleted grafts improves their ex vivo expansion and cytotoxic potential against neuroblastoma: Perspective for optimized immunotherapy post haploidentical stem cell transplantation

Shaping of natural killer cell antitumor activity by ex vivo cultivation

The smac mimetic BV6 improves NK cell-mediated killing of rhabdomyosarcoma cells by simultaneously targeting tumor and effector cells

Relation between acute GVHD and NK cell subset reconstitution following allogeneic stem cell transplantation

Wenn Zellen zu Medikamenten werden : neue Zelltherapien verbessern die Heilungschancen bei Leukämien [[Elektronische Ressource]]

Novel immune modulators used in hematology: impact on NK cells

Lokalisation des antiviralen Mx1-Proteins und seiner assoziierten Proteinkinase in nukleären Einschlusskörpern

Lokalisation des antiviralen Mx1-Proteins und seiner assoziierten Proteinkinase in nukleären Einschlusskörpern